Oncor/NNP Inc./NNP ,/, Gaithersburg/NNP ,/, Md./NNP ,/, said/VBD 0/-NONE- it/PRP received/VBD approval/NN *ICH*-2/-NONE- from/IN the/DT U.S./NNP Food/NNP and/CC Drug/NNP Administration/NNP */-NONE- to/TO market/VB a/DT genetic/JJ test/NN that/WDT *T*-1/-NONE- will/MD assist/VB in/IN diagnosis/NN and/CC treatment/NN of/IN leukemia/NN and/CC lymph/NN cancer/NN ./.
The/DT B$$T/NNP gene/NN rearrangement/NN test/NN is/VBZ more/RBR accurate/JJ than/IN existing/VBG tests/NNS for/IN */-NONE- diagnosing/VBG the/DT type/NN of/IN cancer/NN ,/, whether/IN it/PRP has/VBZ spread/VBN or/CC whether/IN there/EX is/VBZ a/DT recurrence/NN following/VBG treatment/NN ,/, said/VBD 0/-NONE- *T*-1/-NONE- Oncor/NNP President/NNP Stephen/NNP Turner/NNP ./.
Mr./NNP Turner/NNP said/VBD 0/-NONE- the/DT test/NN initially/RB will/MD be/VB used/VBN in/IN conjunction/NN with/IN biopsies/NNS and/CC other/JJ tests/NNS ,/, but/CC eventually/RB might/MD become/VB the/DT benchmark/NN for/IN tumor/NN analysis/NN ./.
Mr./NNP Turner/NNP said/VBD 0/-NONE- the/DT test/NN will/MD be/VB shipped/VBN *-1/-NONE- in/IN 45/CD days/NNS to/TO hospitals/NNS and/CC clinical/JJ laboratories/NNS ./.
Dr./NNP Wyndham/NNP Wilson/NNP ,/, a/DT cancer/NN treatment/NN specialist/NN at/IN the/DT National/NNP Cancer/NNP Institute/NNP ,/, said/VBD 0/-NONE- the/DT test/NN is/VBZ widely/RB used/VBN in/IN research/NN centers/NNS but/CC is/VBZ n't/RB having/VBG a/DT major/JJ impact/NN because/IN it/PRP is/VBZ only/RB occasionally/RB useful/JJ in/IN */-NONE- choosing/VBG the/DT most/JJS effective/JJ treatment/NN ./.
But/CC the/DT test/NN may/MD prove/VB *-1/-NONE- to/TO be/VB more/RBR sensitive/JJ in/IN */-NONE- determining/VBG whether/IN a/DT tumor/NN has/VBZ spread/VBN or/CC returned/VBN following/VBG treatment/NN ,/, Dr./NNP Wilson/NNP said/VBD 0/-NONE- *T*-2/-NONE- ./.
``/`` We/PRP do/VBP n't/RB know/VB yet/RB how/WRB useful/JJ it/PRP 's/VBZ going/VBG */-NONE- to/TO be/VB *T*-2/-NONE- ,/, ''/'' he/PRP said/VBD *T*-1/-NONE- ./.
Oncor/NNP ,/, a/DT six-year-old/JJ developer/NN of/IN genetic/JJ medical/JJ tests/NNS ,/, projects/VBZ that/IN the/DT cancer/NN test/NN will/MD help/VB it/PRP */-NONE- to/TO post/VB its/PRP$ first-ever/JJ profit/NN during/IN the/DT first/JJ quarter/NN of/IN 1990/CD ,/, Mr./NNP Turner/NNP said/VBD 0/-NONE- *T*-1/-NONE- ./.
The/DT company/NN will/MD charge/VB $/$ 35/CD *U*/-NONE- for/IN a/DT test/NN and/CC projects/VBZ about/IN $/$ 2/CD million/CD *U*/-NONE- in/IN revenue/NN from/IN the/DT test/NN during/IN the/DT first/JJ 12/CD months/NNS of/IN marketing/NN ,/, he/PRP said/VBD 0/-NONE- *T*-1/-NONE- ./.

